Skip to main content
    Z

    Zentalis Pharmaceuticals Llc (ZNTL)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.49
    -0.11 (-6.88%)

    Market Cap: $157.22M

    Last updated: Nov 17, 2026 at 4:23 PM ET

    Zentalis Pharmaceuticals Llc (ZNTL) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Zentalis Pharmaceuticals Llc (ZNTL) has a market cap of $157.22M and an enterprise value of $133.20M. Revenue fell 100.00% over the last 12 months from the 12 months before. Its share count is up 17.29% from a year earlier.

    Total Valuation

    Enterprise value is 15.28% below the market cap, as cash exceeds debt.

    Market Cap$157.22M
    Enterprise Value$133.20M
    Latest price (Nov 17, 2026)$1.49

    Key Dates

    The next earnings report is expected on Mar 24, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 24, 2027 (expected)
    Last Earnings DateNov 9, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 18.63% in the quarter ended Sep 30, 2026 and grew 9.08% a year over 2 years.

    Shares Outstanding84.61M
    Shares Change (YoY)+17.29%
    Shares Change (QoQ)+18.63%
    Share Count Growth (2Y CAGR)+9.08%

    Price Statistics

    The stock is up 12.03% over 52 weeks and trades 38.68% below its 50-day average.

    Beta (1Y)1.82
    52-Week Change+12.03%
    1-Month Change-35.22%
    3-Month Change-60.99%
    6-Month Change-57.91%
    5-Year Change-97.56%
    Total Return (1Y)+12.03%
    Total Return (3Y CAGR)-49.17%
    Total Return (5Y CAGR)-54.82%
    Return vs SPY (1Y)-2.00%
    Max Drawdown (1Y)-77.46%
    Max Drawdown (3Y)-93.69%
    Sharpe Ratio (1Y)0.08
    Correlation with SPY (1Y)0.21
    50-Day Average$2.43
    200-Day Average$3.39
    52-Week Range$1.28 to $6.95
    RSI (14 Days)26.7
    Average Volume (20 Days)1.40M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 7.33x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio7.33x
    Quick Ratio7.33x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -69.14% over the last 12 months, against a 5-year average of -55.95%.

    Return on Equity (ROE)-69.14%
    Return on Assets (ROA)-52.43%
    ROE (5Y Average)-55.95%
    ROA (5Y Average)-43.89%
    ROIC (5Y Average)-63.19%

    Scores

    ZNTL has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Gross Profit-$157.00K
    Operating Income-$150.79M
    Pretax Income-$140.85M
    Net Income-$141.67M
    Reported EPS (TTM)-$1.92

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 75.83% of the $270.19M in total assets.

    Cash and Equivalents$24.03M
    Total Debt$0
    Net Cash$24.03M
    Net Cash Per Share$0.28
    Working Capital$204.91M
    Shareholder Equity$204.89M
    Book Value Per Share$2.42
    Total Assets$270.19M
    Total Liabilities$65.31M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$133.84M
    FCF Per Share-$1.36
    Depreciation and Amortization$1.47M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Growth

    Book Value Per Share Growth (2Y CAGR)-30.13%
    Tangible Book Per Share Growth (2Y CAGR)-29.83%

    Revenue and profit by year

    Dividends and Yields

    ZNTL does not pay a dividend.

    Buyback Yield-73.80%
    Shareholder Yield-73.80%

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About ZNTL

    What is ZNTL's market cap?

    Zentalis Pharmaceuticals Llc has a market cap of $157.22M. Its enterprise value, which adds debt and subtracts cash, is $133.20M.

    How many shares of ZNTL are outstanding?

    Zentalis Pharmaceuticals Llc has 84.61M shares outstanding. The count is up 17.29% from a year earlier.

    Does ZNTL pay a dividend?

    No. Zentalis Pharmaceuticals Llc does not pay a dividend.

    How much debt does ZNTL have?

    Zentalis Pharmaceuticals Llc has $0 of total debt and $24.03M of cash and equivalents, a net cash position of $24.03M.